Phase IIb/III data presented for troriluzole in adult patients with spinocerebellar ataxia April 29, 2021
Pharnext reports phase III extension study data on PXT-3003 in Charcot-Marie-Tooth disease type 1A April 29, 2021
Glycine transport inhibitor BI-425809 restores EEG values in a murine model of schizophrenia April 29, 2021
Phase II study finds evidence of improvement with SEP-363856 in psychosis in schizophrenia April 28, 2021